Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment

Supportive Care in Cancer

Volumn 21, Issue 9, 2013, Pages 2565-2573

  Betticher, Daniel C ^a   Delmore, Geoffrey ^b   Breitenstein, Urs ^c   Anchisi, Sandro ^d   Zimmerli Schwab, Beatrice ^e   Müller, Andreas ^f   Von Moos, Roger ^g   Hügli Dayer, Anne Marguerite ^h   Schefer, Hubert ⁱ   Bodenmann, Sereina ^j   Bühler, Vera ^j   Trueb, Ralph R ^k  

^a Hopital Cantonal de Fribourg   (Switzerland)

^b Medizinische Onkologie   (Switzerland)

^c OnkoZentrum Zürich   (Switzerland)

^d Hopital de Sion   (Switzerland)

^e Hopital Pourtales Neuchatelois   (Switzerland)

^f Medizinische Onkologie und Tumorzentrum   (Switzerland)

^g Medizinische Onkologie   (Switzerland)

^h Onkologische Praxis   (Switzerland)

ⁱ Klinik St Anna   (Switzerland)

^j Sanofi Aventis (Suisse) SA   (Switzerland)

^k Dermatologische Praxis and Haarcenter   (Switzerland)

more..

Author keywords

Alopecia; Comparison; Hair loss; Patient reported outcomes; Scalp cooling; Supportive care

Indexed keywords

DOCETAXEL;

ADULT; ALOPECIA; ARTICLE; BREAST CANCER; COLD CAP; COLD SENSATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOLING; COOLING MACHINE; CRYOTHERAPY; FEMALE; HAIR LOSS; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK REDUCTION; SCALP COOLING; SOLID TUMOR;

ADULT; AGED; ALOPECIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; PROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; SCALP; TAXOIDS;

EID: 84881221545     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1804-9     Document Type: Article

References (28)

1. Trueb RM (2010) Chemotherapy-induced alopecia. Curr Opin Support Palliat Care 4(4):281-284
2. Breed W, van den Hurk CJG, Peerbooms M (2011) Presentation, impact and prevention of chemotherapy-induced hair loss. Expert Rev Dermatol 6(1):109-125
3. Lemieux J, Maunsell E, Provencher L (2008) Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology 17(4):317-328 (Pubitemid 351513680)
4. Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D (2004) Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer 12(8):543-549 (Pubitemid 39062544)
5. Pesce A, Cassuto JP, Joyner MV, DuJardin P, Audoly P (1978) Scalp tourniquet in the prevention of chemotherapy-induced alopecia. N Engl J Med 298(21):1204-1205 (Pubitemid 8356497)
6. Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, Trancik RJ, Bandstra BA, Compton LD (1996) A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol 35(1):74-78 (Pubitemid 26231327)
7. Davis ST, Benson BG, Bramson HN, Chapman DE, Dickerson SH, Dold KM, Eberwein DJ, Edelstein M, Frye SV, Gampe RT Jr, Griffin RJ, Harris PA, Hassell AM, Holmes WD, Hunter RN, Knick VB, Lackey K, Lovejoy B, Luzzio MJ, Murray D, Parker P, Rocque WJ, Shewchuk L, Veal JM, Walker DH, Kuyper LF (2001) Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science 291(5501):134-137 (Pubitemid 32056682)
8. Breed WP (2004) What is wrong with the 30-year-old practice of scalp cooling for the prevention of chemotherapy-induced hair loss? Support Care Cancer 12(1):3-5 (Pubitemid 38133503)
9. Grevelman EG, Breed WP (2005) Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 16(3):352-358 (Pubitemid 40458310)
10. Paxman Coolers Ltd. Paxman PSC-2 broschure. Internet: http://ebookbrowse.com/psc2-manual-pdf-d234169346. Accessed on 9 September 2012
11. Bulow J, Friberg L, Gaardsting O, Hansen M (1985) Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man. Scand J Clin Lab Invest 45(6):505-508 (Pubitemid 16225732)
12. Ridderheim M, Bjurberg M, Gustavsson A (2003) Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer 11(6):371-377 (Pubitemid 36734170)
13. Macduff C, Mackenzie T, Hutcheon A, Melville L, Archibald H (2003) The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. Eur J Cancer Care 12(2):154-161 (Pubitemid 37260168)
14. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649-655 (Pubitemid 13149996)
15. World Health Organisation Handbook for reporting results of cancer treatment. WHO Offset Publications, Geneva, 1979. Internet: http://whqlibdoc. who.int/offset/WHO-OFFSET-48.pdf. Accessed on 10 January 2013
16. van den Hurk C, Breed W, Nortier J (2009) Short post-infusion cooling time of scalp cooling in the prevention of docetaxel-induced hair loss.Poster presentation at the Annual Meeting of the European Cancer Organisation (ECCO), 20-24 September 2009, Berlin, Germany
17. Ottevanger PB, Therasse P, van de Velde C, Bernier J, van Krieken H, Grol R, De Mulder P (2003) Quality assurance in clinical trials. Crit Rev Oncol Hematol 47(3):213-235 (Pubitemid 37074855)
18. Edelstyn GA, MacDonald M, MacRae KD (1977) Doxorubicin-induced hair loss and possible modification by scalp cooling. Lancet 2(8031):253-254 (Pubitemid 8120669)
19. Giaccone G, Di Giulio F, Morandini MP, Calciati A (1988) Scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer Nurs 11(3):170-173
20. Parker R (1987) The effectiveness of scalp hypothermia in preventing cyclophosphamide-induced alopecia. Oncol Nurs Forum 14(6):49-53
21. Ron IG, Kalmus Y, Kalmus Z, Inbar M, Chaitchik S (1997) Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy. Support Care Cancer 5(2):136-138 (Pubitemid 27163455)
22. Satterwhite B, Zimm S (1984) The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer 54(1):34-37 (Pubitemid 14117042)
23. Auvinen PK, Mahonen UA, Soininen KM, Paananen PK, Ranta-Koponen PH, Saavalainen IE, Johansson RT (2010) The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia. Tumori 96(2):271-275
24. van den Hurk CJ, Breed WP, Nortier JW (2012) Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 20(12):3255-3260
25. van den Hurk C Synoptic report in: Paxman clinical report summary of scalp cooling efficacy, page 10. Version 04-11. Internet: http://www.paxman- coolers.co.uk/index.php/professionals/professionals-downloads/. Accessed on 9. September 2012
26. Massey CS (2004) A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy. Eur J Oncol Nurs 8(2):121-130 (Pubitemid 38811749)
27. van den Hurk CJ, Peerbooms M, van de Poll-Franse LV, Nortier JW, Coebergh JW, Breed WP (2012) Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry. Acta Oncol 51(4):497-504
28. Delgado-Rodriguez M, Llorca J (2004) Bias. J Epidemiol Community Health 58(8):635-641